Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I/II Trial Of MGI114 For Treatment Of Patients With Recurrent Malignant Gliomas

NCT00012038 is registered in ClinicalTrials.gov with New Approaches to Brain Tumor Therapy Consortium as lead sponsor.

NCT NCT00012038
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00012038 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I/II Trial Of MGI114 For Treatment Of Patients With Recurrent Malignant Gliomas
Lead sponsor
New Approaches to Brain Tumor Therapy Consortium
Phase
Phase 1/2
Overall status
Completed
Start date
July 31, 2001
Completion date
October 31, 2003
Enrollment
Not reported
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

brain and central nervous system tumors